Home / Pharmaceutical company intelligence
CRYSTOLITE PHARMACEUTICALS logo
Pharmaceutical company intelligence

CRYSTOLITE PHARMACEUTICALS products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-area pharmaceutical manufacturer established in 2004, manufacturing and marketing pharmaceutical and healthcare products for domestic and export markets.

CRYSTOLITE PHARMACEUTICALS products in Pakistan

CRYSTOLITE PHARMACEUTICALS has 130 medicine presentations registered in Pakistan under 74 brands, covering 67 generic medicines. Most of its products are in Anti-infectives, Dermatology and Cardiovascular. Its brands with the most registered strengths and packs are Zucker (Empagliflozin), Oratane (Isotretinoin), Bptin-H (Amlodipine + Valsartan + Hydrochlorothiazide) and Romlus (Tacrolimus). 130 products have an official DRAP price on MedInfoBase. See all 74 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation10 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
Plot #1 & 2, Street S-2, National Industrial Zone, Rawat, Islamabad, Pakistan
Phone
+92 342 0022555
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000778 Crystolite Pharmaceuticals. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000778 130 linked products · source seen 10 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx154public portfolio records represented
REG129unique registrations represented
IDX130indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+24registry-only registrations
VER68registry-verified exact registrations
PKR130current validated price records
G67generic molecules in indexed catalogue
DF10dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage84%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage74%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixCRYSTOLITE PHARMACEUTICALSShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/crystolite-pharmaceuticalsGenerated 10 Nov 2026Anti-infectives54 · 42%Dermatology20 · 15%Cardiovascular15 · 12%Oncology & immunology10 · 8%CNS & mental health9 · 7%Vitamins, minerals & nutrition7 · 5%Endocrine & metabolic7 · 5%Other therapeutic areas8 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioCRYSTOLITE PHARMACEUTICALSDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/crystolite-pharmaceuticalsGenerated 10 Nov 2026130presentationsTablet59 · 45%Capsule21 · 16%Lotion17 · 13%Cream9 · 7%Injection6 · 5%Syrup6 · 5%Other forms12 · 9%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionCRYSTOLITE PHARMACEUTICALSCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/crystolite-pharmaceuticalsGenerated 10 Nov 202696comparable productsBelow peer median11 · 11%Near peer median50 · 52%Above peer median35 · 36%Company median price position+2.7%Lowest-price equivalents8Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsCRYSTOLITE PHARMACEUTICALSCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/crystolite-pharmaceuticalsGenerated 10 Nov 2026Nabiqasim Industries (Pvt) Ltd.,37 shared55% overlapValor Pharmaceuticals34 shared51% overlapShaigan Pharmaceuticals (Pvt) Ltd34 shared51% overlapNeutro Pharma (Pvt.) Ltd.,33 shared49% overlapPharmasol (Pvt) Ltd.32 shared48% overlapMediate Pharmaceutical Pvt Ltd32 shared48% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet59 products
Capsule21 products
Lotion17 products
Cream9 products
Injection6 products
Syrup6 products
Gel4 products
Sachet3 products
Suspension3 products
Ointment2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where CRYSTOLITE PHARMACEUTICALS is priced against the market

96 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers105Distinct registrations among indexed, published, presentation-validated products only
Verified price observations130
Products with a verified price130
Products with multiple price observations0
Source records with multiple versions130
Latest portfolio source check12 Oct 2026
Latest effective price date27 Jul 2026
Latest source observation10 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

129 unique registration(s) · 130 indexed presentation(s) · 24 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Adnast Anastrozole 1 mg Tablet 28’s 088459 PKR 9,550.61 PKR 341.09/tablet 🔒 Pharma Pro
Anlev Levofloxacin 500 mg Tablet 10’s 077610 PKR 829.80 PKR 82.98/tablet 🔒 Pharma Pro
Anlev Levofloxacin 250 mg Tablet 1x10’s 078019 PKR 498.67 PKR 49.87/tablet 🔒 Pharma Pro
Asitor-C Amlodipine 10 mg Tablet 20’s 082448 PKR 627.25 PKR 31.36/tablet 🔒 Pharma Pro
Asitor-C 10 Amlodipine + Atorvastatin 10 mg + 10 mg Tablet 14’s 082449 PKR 503.72 PKR 35.98/tablet 🔒 Pharma Pro
Asset Acitretin 25 mg Capsule 30’s 077615 PKR 2,546.20 PKR 84.87/capsule 🔒 Pharma Pro
Atravia 0.75mg TabletsRegistry verified Atrasentan HCl 0.803 mg eq. to Atrasentan — — — 137073Official source ↗ No indexed price — —
Bptin-H Amlodipine + Valsartan + Hydrochlorothiazide 5 mg + 12.5 mg + 160 mg Tablet 14’s 101830 PKR 233.24 PKR 16.66/tablet 🔒 Pharma Pro
Bptin-H Amlodipine + Valsartan + Hydrochlorothiazide 10 mg + 25 mg + 160 mg Tablet 14’s 101831 PKR 255.72 PKR 18.27/tablet No comparator
Bptin-H Amlodipine + Valsartan + Hydrochlorothiazide 10 mg + 25 mg + 320 mg Tablet 14’s 101832 PKR 393.41 PKR 28.10/tablet No comparator
Bptin-H Amlodipine + Valsartan + Hydrochlorothiazide 5 mg + 25 mg + 160 mg Tablet 14’s 101833 PKR 238.85 PKR 17.06/tablet No comparator
Bptin10 Amlodipine + Valsartan 10 mg + 160 mg Tablet 14’s 082431 PKR 751.14 PKR 53.65/tablet 🔒 Pharma Pro
Bptin5 Amlodipine + Valsartan 5 mg + 160 mg Tablet 14’s 082430 PKR 640.13 PKR 45.72/tablet 🔒 Pharma Pro
Bptin5 Amlodipine + Valsartan 5 mg + 80 mg Tablet 14’s 082432 PKR 447.73 PKR 31.98/tablet 🔒 Pharma Pro
C-Val Plus Hydrochlorothiazide 80 mg Tablet 28’s 082436 PKR 677.14 PKR 24.18/tablet 🔒 Pharma Pro
C-Val Plus Valsartan + Hydrochlorothiazide 12.5 mg + 160 mg Tablet 14’s 082437 PKR 547.63 PKR 39.12/tablet No comparator
C-Val Plus 25 Valsartan + Hydrochlorothiazide 25 mg + 160 mg Tablet 14’s 082438 PKR 573.53 PKR 40.97/tablet No comparator
Calpsor Calcipotriol 50 mcg/mL Lotion 30ml 077719 PKR 1,519.57 PKR 50.65/mL No comparator
Calpsor-B Calcipotriol + Betamethasone 50 mcg/mL + 500 mcg/mL Lotion 30ml 077720 PKR 1,502.41 PKR 50.08/mL No comparator
Canix Clotrimazole 10 mg/mL Lotion 30ml 077643 PKR 63.06 PKR 2.10/mL 🔒 Pharma Pro
Canix Clotrimazole 10 mg/mL (1%) Lotion 60ml 077643 PKR 119.83 PKR 2.00/mL No comparator
Canix Clotrimazole 1% Cream 15gm 082321 PKR 95.74 PKR 6.38/g 🔒 Pharma Pro
Canix 500mg vaginal tabletRegistry verified Clotrimazole — — — 110755Official source ↗ No indexed price — —
Canix W/W Clotrimazole 1 % Cream 10gm 082321 PKR 63.82 PKR 6.38/g 🔒 Pharma Pro
Canix-H Clotrimazole + Hydrocortisone 10 mg + 10 mg Cream 10gm 077636 PKR 114.05 PKR 11.41/g 🔒 Pharma Pro
Canix-H Clotrimazole + Hydrocortisone 10 mg + 10 mg Cream 15gm 077636 PKR 171.08 PKR 11.41/g 🔒 Pharma Pro
Canix-H Clotrimazole + Hydrocortisone 10 mg + 10 mg Cream 20gm 077636 PKR 210.42 PKR 10.52/g 🔒 Pharma Pro
Cifram Ciprofloxacin 250 mg Tablet 10’s 077612 PKR 259.32 PKR 25.93/tablet 🔒 Pharma Pro
Cifram Ciprofloxacin 500 mg Tablet 10’s 077613 PKR 428.86 PKR 42.89/tablet 🔒 Pharma Pro
Cimox Moxifloxacin 400 mg Tablet 5’s 077608 PKR 947.48 PKR 189.50/tablet 🔒 Pharma Pro
Clarger 250mg tabletRegistry verified Clarithromycin — — — 109363Official source ↗ No indexed price — —
Clindaben Clindamycin 10 mg Gel 10gm 093396 PKR 448.44 PKR 44.84/g 🔒 Pharma Pro
Cosalic Salicylic acid + Coal tar + Hydrocortisone 3% + 3% + 1% Lotion 60ml 077653 PKR 613.95 PKR 10.23/mL No comparator
Cosalic Salicylic acid + Coal tar + Hydrocortisone 3% + 3% + 1% Lotion 30ml 077653 PKR 323.13 PKR 10.77/mL No comparator
Crystra Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120’s 102659 PKR 12,331.99 PKR 102.77/tablet 🔒 Pharma Pro
Crysvir Oseltamivir 75 mg Capsule 10’s 102660 PKR 1,384.94 PKR 138.49/capsule 🔒 Pharma Pro
Daclavir Daclatasvir 30 mg Tablet 28’s 085241 PKR 5,549.24 PKR 198.19/tablet 🔒 Pharma Pro
Daclavir Daclatasvir 60 mg Tablet 28’s 085242 PKR 9,079.86 PKR 324.28/tablet 🔒 Pharma Pro
Daskil Terbinafine 1 % Cream 10gm 077624 PKR 294.42 PKR 29.44/g 🔒 Pharma Pro
Delgo 2% CreamRegistry verified Delgocitinib — — — 135563Official source ↗ No indexed price — —
Differin Adapalene + Benzoyl peroxide 0.1% + 2.5% Gel 15gm 077633 PKR 324.53 PKR 21.64/g No comparator
Differin Adapalene + Benzoyl peroxide 0.1% + 2.5% Gel 30gm 077633 PKR 584.93 PKR 19.50/g No comparator
Dopiral Clopidogrel 75 mg Tablet 10’s 082450 PKR 279.26 PKR 27.93/tablet 🔒 Pharma Pro
Duphalite 10mg TabletRegistry verified DYDROGESTERONE — — — 134170Official source ↗ No indexed price — —
Ecozone Cefotaxime 250 mg IV/IM injection 1’s 089548 PKR 113.21 PKR 113.21/vial/unit 🔒 Pharma Pro
Ecozone Cefotaxime 500 mg IV/IM injection 1’s 089549 PKR 170.62 PKR 170.62/vial/unit 🔒 Pharma Pro
Ecozone Cefotaxime 1 g IV/IM injection 1’s 089550 PKR 306.88 PKR 306.88/vial/unit 🔒 Pharma Pro
Endovera 100mg TabletRegistry verified Linzagolix Choline eq. to Linzagolix — — — 138239Official source ↗ No indexed price — —
Endovera 200mg TabletRegistry verified Linzagolix Choline eq. to Linzagolix — — — 138240Official source ↗ No indexed price — —
Entaliv-b Entecavir 0.5 mg Tablet 3x10’s 090023 PKR 12,965.53 PKR 432.18/tablet 🔒 Pharma Pro
A to Z

All 74 CRYSTOLITE PHARMACEUTICALS brands in Pakistan

  • Adnast Anastrozole · 1 mg tablet
  • Anlev Levofloxacin · 250 mg tablet, 500 mg tablet
  • Asitor-C Amlodipine · 10 mg tablet
  • Asitor-C 10 Amlodipine + Atorvastatin · 10 mg + 10 mg tablet
  • Asset Acitretin · 25 mg capsule
  • Bptin-H Amlodipine + Valsartan + Hydrochlorothiazide · 10 mg + 25 mg + 160 mg tablet, 10 mg + 25 mg + 320 mg tablet, 5 mg + 12.5 mg + 160 mg tablet
  • Bptin10 Amlodipine + Valsartan · 10 mg + 160 mg tablet
  • Bptin5 Amlodipine + Valsartan · 5 mg + 160 mg tablet, 5 mg + 80 mg tablet
  • C-Val Plus Valsartan + Hydrochlorothiazide, Hydrochlorothiazide · 12.5 mg + 160 mg tablet, 80 mg tablet
  • C-Val Plus 25 Valsartan + Hydrochlorothiazide · 25 mg + 160 mg tablet
  • Calpsor Calcipotriol · 50 mcg/mL lotion
  • Calpsor-B Calcipotriol + Betamethasone · 50 mcg/mL + 500 mcg/mL lotion
  • Canix Clotrimazole · 1% cream, 10 mg/mL lotion, 10 mg/mL (1%) lotion
  • Canix W/W Clotrimazole · 1 % cream
  • Canix-H Clotrimazole + Hydrocortisone · 10 mg + 10 mg cream
  • Cifram Ciprofloxacin · 250 mg tablet, 500 mg tablet
  • Cimox Moxifloxacin · 400 mg tablet
  • Clindaben Clindamycin · 10 mg gel
  • Cosalic Salicylic acid + Coal tar + Hydrocortisone · 3% + 3% + 1% lotion
  • Crystra Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • Crysvir Oseltamivir · 75 mg capsule
  • Daclavir Daclatasvir · 30 mg tablet, 60 mg tablet
  • Daskil Terbinafine · 1 % cream
  • Differin Adapalene + Benzoyl peroxide · 0.1% + 2.5% gel
  • Dopiral Clopidogrel · 75 mg tablet
  • Ecozone Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Entaliv-b Entecavir · 0.5 mg tablet
  • Epiwin Sodium valproate · 250 mg/5 mL syrup
  • Fermin Elemental Iron, Iron polymaltose complex · 100 mg tablet, 50 mg/5 mL syrup
  • Fermin Plus Iron + Folic acid, Iron polymaltose complex + Folic acid · 0.35 mg/5 mL + 0.35 mg/5 mL syrup, 50 mg elemental iron + 0.35 mg folic acid/5 mL syrup
  • Fertomid Clomifene citrate · 50 mg tablet
  • Fumac Fluconazole · 150 mg capsule
  • Hep-C-Vir Sofosbuvir · 400 mg tablet
  • Hepled Sofosbuvir · 90 mg tablet
  • Hospilid Linezolid · 600 mg tablet
  • Imulite Azathioprine · 50 mg tablet
  • Imun Heoral Soft Ciclosporin · 100 mg capsule, 25 mg capsule, 50 mg capsule
  • Imutrex Methotrexate · 2.5 mg tablet
  • Lipsore Aciclovir · 5 % cream
  • Lorlite Loratadine · 10 mg tablet
  • Makazi Azithromycin · 250 mg capsule, 500 mg tablet
  • Micosone Miconazole + Hydrocortisone · 2% w/v + 1% w/v lotion, 20 mg/mL + 10 mg/mL lotion
  • Movinate Polyethylene glycol 3350 + Sodium chloride + Sodium bicarbonate + Potassium chloride · 13.125 g + 0.3507 g + 0.1785 g + 0.0466 g per sachet sachet
  • Muricin Mupirocin · 2% ointment
  • No Boyle B Fusidic acid + Betamethasone valerate · 2% + 0.1% cream
  • No-Boyle-H Fusidic acid + Hydrocortisone acetate · 2% + 1% cream
  • Nurotop Carbamazepine · 100 mg/5 mL suspension, 200 mg tablet, 400 mg tablet
  • Oliprox-S Ciclopirox olamine + Salicylic acid · 15 mg/mL + 30 mg/mL lotion
  • Oracea Doxycycline · 100 mg tablet
  • Oratane Isotretinoin · 10 mg capsule, 20 mg capsule
  • Oratraxin Isotretinoin · 0.5 mg gel
  • Oraz Omeprazole · 40 mg capsule
  • Oraz 20 Omeprazole · 20 mg capsule
  • Oraz Insta 20/1680 Omeprazole · 20 mg sachet
  • Oraz Insta 40/1680 Omeprazole · 40 mg sachet
  • Orcef Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
  • Osotax Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Portakal Ascorbic acid · 500 mg tablet
  • Romlus Tacrolimus · 0.5 mg capsule, 1 mg capsule
  • Scabi-Cap Permethrin · 5% w/v lotion, 50 mg/mL (5%) lotion
  • Sepavir Sofosbuvir · 400 mg tablet
  • Solar-D Soft Gelatin Cholecalciferol · 1.25 mg capsule
  • Speridon Risperidone · 2 mg tablet, 3 mg tablet, 4 mg tablet
  • Telmi Telmisartan · 20 mg tablet, 40 mg tablet, 80 mg tablet
  • Tenfavir Tenofovir disoproxil · 300 mg tablet
  • Twoprox CR Divalproex sodium · 500 mg tablet
  • Valisone-C Betamethasone + Clotrimazole · 0.5 mg/mL + 10 mg/mL lotion, 500 mcg + 1 mg/mL lotion
  • Valisone-S Betamethasone + Salicylic acid · 0.05% w/v + 3% w/v lotion, 0.5 mg + 30 mg ointment
  • Virofix Ribavirin · 200 mg tablet, 400 mg tablet
  • Virofix 600 Ribavirin · 600 mg tablet
  • Wart-Off Salicylic acid + Lactic acid · 167 mg/mL + 167 mg/mL lotion
  • Zanzara Chloroquine · 250 mg tablet
  • Zanzara-H Hydroxychloroquine · 200 mg tablet
  • Zucker Empagliflozin · 12.5 mg tablet, 5 mg tablet
Questions

CRYSTOLITE PHARMACEUTICALS: common questions

How many products does CRYSTOLITE PHARMACEUTICALS have in Pakistan?

CRYSTOLITE PHARMACEUTICALS has 130 registered medicine presentations in Pakistan, sold under 74 brands and covering 67 generic medicines.

What are the main brands of CRYSTOLITE PHARMACEUTICALS?

By number of registered strengths and packs, its largest brands are Zucker (Empagliflozin), Oratane (Isotretinoin), Bptin-H (Amlodipine + Valsartan + Hydrochlorothiazide), Romlus (Tacrolimus) and Canix (Clotrimazole). This is not a sales ranking.

Which therapy areas does CRYSTOLITE PHARMACEUTICALS cover?

The most products are in Anti-infectives (53), Dermatology (21), Cardiovascular (15), Oncology & immunology (10) and CNS & mental health (9).

Where can I see CRYSTOLITE PHARMACEUTICALS medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). CRYSTOLITE PHARMACEUTICALS — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 10, 2026, from https://medinfobase.com/company/crystolite-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9